Nova Eye Medical Limited Share Price
Equities
EYE
AU0000094252
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.275 AUD | 0.00% | +7.84% | +14.58% |
03-15 | Nova Eye Medical Completes Retail Entitlement Offer | MT |
02-22 | Nova Eye Medical Limited Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
Sales 2024 * | 22M 14.44M 1.15B | Sales 2025 * | 30.7M 20.15M 1.61B | Capitalization | 62.92M 41.29M 3.3B |
---|---|---|---|---|---|
Net income 2024 * | -8M -5.25M -419M | Net income 2025 * | -1M -656K -52.38M | EV / Sales 2024 * | 2.54 x |
Net cash position 2024 * | 7M 4.59M 367M | Net cash position 2025 * | 4.4M 2.89M 230M | EV / Sales 2025 * | 1.91 x |
P/E ratio 2024 * |
-6.29
x | P/E ratio 2025 * |
-22.2
x | Employees | 301 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 89.39% |
Latest transcript on Nova Eye Medical Limited
1 week | +7.84% | ||
Current month | +19.57% | ||
1 month | +14.58% | ||
3 months | -1.79% | ||
6 months | +48.65% | ||
Current year | +14.58% |
Managers | Title | Age | Since |
---|---|---|---|
Thomas Spurling
CEO | Chief Executive Officer | - | 30/03/11 |
David Lubeck
CTO | Chief Tech/Sci/R&D Officer | - | 17/10/18 |
Mark Flynn
IRC | Investor Relations Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Victor Previn
FOU | Founder | 65 | 31/12/84 |
Thomas Spurling
CEO | Chief Executive Officer | - | 30/03/11 |
Rahmon Coupe
BRD | Director/Board Member | 60 | 14/05/13 |
Date | Price | Change | Volume |
---|---|---|---|
29/04/24 | 0.275 | 0.00% | 814 489 |
26/04/24 | 0.275 | +1.85% | 150,249 |
24/04/24 | 0.27 | +1.89% | 536,808 |
23/04/24 | 0.265 | +3.92% | 300,127 |
22/04/24 | 0.255 | +2.00% | 132,153 |
Delayed Quote Australian S.E., April 29, 2024 at 07:10 am
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+14.58% | 41.03M | |
+8.07% | 219B | |
+6.59% | 183B | |
+11.26% | 133B | |
+26.57% | 108B | |
+2.28% | 63.06B | |
+13.35% | 52.02B | |
-0.62% | 48.2B | |
-0.93% | 40.37B | |
+11.54% | 39.35B |
- Stock Market
- Equities
- EYE Stock